beta-lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca

beta-Lactamase gene promoters of 45 clinical Klebsiella oxytoca isolates resistant to beta-lactams and exhibiting beta-lactamase hyperproduction differed from those in 26 susceptible strains. Direct sequencing revealed one mutation in either the -10 or -35 conserved sequences: a G-to-A transition of the fifth base (67%) or a G-to-T transversion of the first base of the -10 sequence (27%) or a T-to-A transversion in the fourth base in the -35 sequence (4%). One strain carried both the -10 transition and the -35 transversion.

[1]  P. H. Roy,et al.  Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2 , 1996, Antimicrobial agents and chemotherapy.

[2]  D. Livermore beta-Lactamases in laboratory and clinical resistance , 1995, Clinical microbiology reviews.

[3]  P. Lagrange,et al.  Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca , 1995, Antimicrobial agents and chemotherapy.

[4]  D. Monnet,et al.  Method for differentiating Klebsiella planticola and Klebsiella terrigena from other Klebsiella species , 1994, Journal of clinical microbiology.

[5]  P. Lagrange,et al.  Klebsiella oxytoca: Resistance to aztreonam by overproduction of the chromosomally encoded β‐lactamase , 1994 .

[6]  C. Soussy,et al.  Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France , 1992, Antimicrobial Agents and Chemotherapy.

[7]  D. Snydman Clinical implications of multi-drug resistance in the intensive care unit. , 1991, Scandinavian journal of infectious diseases. Supplementum.

[8]  J. Wagenvoort,et al.  Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. The 1990 Dutch Surveillance Study. , 1991, Scandinavian journal of infectious diseases. Supplementum.

[9]  P. Shah,et al.  Incidence of multi-resistance in gram-negative aerobes from intensive care units of 10 German hospitals. , 1991, Scandinavian journal of infectious diseases. Supplementum.

[10]  Akira Ishihama,et al.  Promoter selectivity of Escherichia coli RNA polymerase: effect of base substitutions in the promoter -35 region on promoter strength. , 1990, Nucleic acids research.

[11]  M. Mori,et al.  Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics , 1989, Antimicrobial Agents and Chemotherapy.

[12]  荒川 宜親 Chromosomal β-lactamase of Klebsiella oxytoca, a new class a enzyme that hydrolyzes broad-spectrum β-lactam antibiotics , 1989 .

[13]  G. Paul,et al.  Immunological comparison of constitutive beta-lactamases of gram-negative bacteria by neutralization in zymogram gels: properties of anti-TEM-1 and anti-TEM-2 sera. , 1988, Annales de l'Institut Pasteur. Microbiology.

[14]  D. K. Hawley,et al.  Compilation and analysis of Escherichia coli promoter DNA sequences. , 1983, Nucleic acids research.

[15]  T. Grundström,et al.  Sequence elements determining ampC promoter strength in E. coli. , 1982, The EMBO journal.

[16]  Y. Anraku The reduction and restoration of galactose transport in osmotically shocked cells of Escherichia coli. , 1967, The Journal of biological chemistry.